Islet-released mediators impact transplant outcome

September 7, 2017

(HealthDay)—Cytokines and chemokines produced by pancreatic islets in response to inflammatory and metabolic stress include interferon gamma-induced protein 10 (IP-10/CXCL10), which is associated with poor islet transplant outcomes, according to a study published in the September issue of Diabetes.

Gumpei Yoshimatsu, M.D., Ph.D., from the Baylor Research Institute in Dallas, and colleagues examined the physiological role of "isletokines" produced by in response to inflammatory and .

The researchers found that for patients undergoing , islets released multiple inflammatory mediators within hours of infusion. Among the highest-released was IP-10; high levels correlated with poor islet transplant outcomes. The contribution of donor islet-specific expression of IP-10 to islet inflammation and loss of beta-cell function in islet grafts was confirmed in transgenic mouse studies. Treatment of donor islets and recipient mice with anti-IP-10 neutralizing monoclonal antibody blocked the effects of islet-derived IP-10. IP-10 gene induction was mediated by calcineurin-dependent NFAT signaling in in response to oxidative or inflammatory stress. P38 and JNK MAP kinase (MAPK) activity were required for the sustained correlation of NFAT and p300 histone acetyltransferase with the IP-10 gene, which differentially regulated expression of IP-10 and subsequent release of protein.

"These findings elucidate an NFAT-MAPK signaling paradigm for induction of isletokine expression in beta-cells and reveal IP-10 as a primary therapeutic target to prevent beta-cell-induced inflammatory loss of graft function after islet cell transplantation," the authors write.

The study was funded in part by Roche Diagnostic Corp.

Explore further: The best place to treat type 1 diabetes might be just under your skin

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

The best place to treat type 1 diabetes might be just under your skin

August 14, 2017
A group of U of T researchers have demonstrated that the space under our skin might be an optimal location to treat type 1 diabetes (T1D).

New procedure could improve success rate of cell transplant to cure type 1 diabetes

April 4, 2016
New research suggests pretreating cells with a peptide hormone may improve the success rate of pancreatic islet cell transplants, a procedure that holds great promise for curing Type 1 diabetes. The results will be presented ...

Novel tissue-engineered islet transplant achieves insulin independence in type 1 diabetes

May 11, 2017
Scientists from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine have produced the first clinical results demonstrating that pancreatic islet cells transplanted within a tissue-engineered ...

Pancreatic islets infusion for diabetes patient being readied for procedure in Japan

May 16, 2012
The Japanese Pancreas and Islet Transplantation Association (JPITA) is preparing for the nation's first transplantation of pancreatic islets from a brain-dead donor to a patient with Type 1 diabetes, it was learned Saturday.

Recommended for you

Genetic discovery may help better identify children at risk for type 1 diabetes

January 17, 2018
Six novel chromosomal regions identified by scientists leading a large, prospective study of children at risk for type 1 diabetes will enable the discovery of more genes that cause the disease and more targets for treating ...

Thirty-year study shows women who breastfeed for six months or more reduce their diabetes risk

January 16, 2018
In a long-term national study, breastfeeding for six months or longer cuts the risk of developing type 2 diabetes nearly in half for women throughout their childbearing years, according to new Kaiser Permanente research published ...

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.